Found 2591 results
Author Title Type [ Year(Asc)]
V. Schiariti, Fowler, E., Brandenburg, J. E., Levey, E., Mcintyre, S., Sukal-Moulton, T., Ramey, S. L., Rose, J., Sienko, S., Stashinko, E., Vogtle, L., Feldman, R. S., and Koenig, J. I., A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations., Dev Med Child Neurol, vol. 60, no. 10, pp. 976-986, 2018.
J. D. Lee, Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., K Peavy, M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablein, D., Subramaniam, G., and Rotrosen, J., Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial., Lancet, vol. 391, no. 10118, pp. 309-318, 2018.
T. G. Elliott, Dooley, K. C., Zhang, M., Campbell, H. S. D., and Thompson, D. J. S., Comparison of Glycated Hemoglobin Results Based on At-Home and In-Lab Dried Blood Spot Sampling to Routine Venous Blood Sampling In-Lab in Adult Patients With Type 1 or Type 2 Diabetes., Can J Diabetes, vol. 42, no. 4, pp. 426-432.e1, 2018.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Altaweel, M., and Berinstein, D. M., Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial., JAMA Ophthalmol, vol. 136, no. 4, pp. 337-345, 2018.
T. Peto, Heeren, T. F. C., Clemons, T. E., Sallo, F. B., Leung, I., Chew, E. Y., and Bird, A. C., CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group., Retina, vol. 38 Suppl 1, pp. S8-S13, 2018.
A. Y. Lee, Butt, T., Chew, E., Agrón, E., Clemons, T. E., Egan, C. A., Lee, C. S., and Tufail, A., Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data., Br J Ophthalmol, vol. 102, no. 4, pp. 465-472, 2018.
M. Girotra, Hansen, A., Farooki, A., Byun, D. J., Min, L., Creelan, B. C., Callahan, M. K., Atkins, M. B., Sharon, E., Antonia, S. J., West, P., and Gravell, A. E., The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management., JNCI Cancer Spectr, vol. 2, no. 3, p. pky021, 2018.
V. Huser and Shmueli-Blumberg, D., Data sharing platforms for de-identified data from human clinical trials., Clin Trials, vol. 15, no. 4, pp. 413-423, 2018.
F. van Asten, Simmons, M., Singhal, A., Keenan, T. D., Ratnapriya, R., Agrón, E., Clemons, T. E., Swaroop, A., Lu, Z., and Chew, E. Y., A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14., Ophthalmology, vol. 125, no. 4, pp. 559-568, 2018.
K. V. Houser, Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Paskel, M., Subbarao, K., Anderson, E., Bernstein, D. I., Creech, B., Keyserling, H., Spearman, P., Wright, P. F., Graham, B. S., and Ledgerwood, J. E., DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial., PLoS One, vol. 13, no. 11, p. e0206837, 2018.
L. M. Turcotte, DeFor, T. E., Newell, L. F., Cutler, C. S., Verneris, M. R., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Vercellotti, G. M., Slungaard, A., Blazar, B. R., Weisdorf, D. J., Panoskaltsis-Mortari, A., and Holtan, S. G., Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402., Bone Marrow Transplant, vol. 53, no. 1, pp. 64-68, 2018.
M. Fazlollahi, Chun, Y., Grishin, A., Wood, R. A., Burks, A. W., Dawson, P., Jones, S. M., Leung, D. Y. M., Sampson, H. A., Sicherer, S. H., and Bunyavanich, S., Early-life gut microbiome and egg allergy., Allergy, vol. 73, no. 7, pp. 1515-1524, 2018.
R. Spellecy, Tarima, S., Denzen, E., Moore, H., Abhyankar, S., Dawson, P., Foley, A., Gersten, I., Horwitz, M., Idossa, L., Joffe, S., Kamani, N., King, R., Lazaryan, A., Morris, L., Horowitz, M. M., and Majhail, N. S., Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study., Biol Blood Marrow Transplant, vol. 24, no. 10, pp. 2145-2151, 2018.
D. G. Birch, Bernstein, P. S., Iannacone, A., Pennesi, M. E., Lam, B. L., Heckenlively, J., Csaky, K., Hartnett, M. Elizabeth, Winthrop, K. L., Jayasundera, T., Hughbanks-Wheaton, D. K., Warner, J., Yang, P., Fish, G. Edd, Teske, M. P., Sklaver, N. L., Erker, L., Chegarnov, E., Smith, T., Wahle, A., VanVeldhuisen, P. C., McCormack, J., Lindblad, R., Bramer, S., Rose, S., Zilliox, P., Francis, P. J., and Weleber, R. G., Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial., JAMA Ophthalmol, vol. 136, no. 8, pp. 849-856, 2018.
C. M Berin, Grishin, A., Masilamani, M., Leung, D. Y. M., Sicherer, S. H., Jones, S. M., A Burks, W., Henning, A. K., Dawson, P., Grabowska, J., Agashe, C., Davidson, W. F., Wood, R. A., and Sampson, H. A., Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy., J Allergy Clin Immunol, vol. 142, no. 1, pp. 149-158.e8, 2018.
E. H. Payne, Gebregziabher, M., Hardin, J. W., Ramakrishnan, V., and Egede, L. E., An empirical approach to determine a threshold for assessing overdispersion in Poisson and negative binomial models for count data., Commun Stat Simul Comput, vol. 47, no. 6, pp. 1722-1738, 2018.
P. Nachipo, Hermann, D., Quinnan, G., Gordon, M. A., Van Voorhis, W. C., and Tam, P. - Y. Iroh, Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial., Trials, vol. 19, no. 1, p. 456, 2018.
P. A. Wetzel, Lindblad, A. S., Raizada, H., James, N., Mulatya, C., Kannan, M. A., Villamar, Z., Gitchel, G. T., and Weaver, L. K., Eye Tracking Results in Postconcussive Syndrome Versus Normative Participants., Invest Ophthalmol Vis Sci, vol. 59, no. 10, pp. 4011-4019, 2018.
Q. Yan, Ding, Y., Liu, Y., Sun, T., Fritsche, L. G., Clemons, T., Ratnapriya, R., Klein, M. L., Cook, R. J., Liu, Y., Fan, R., Wei, L., Abecasis, G. R., Swaroop, A., Chew, E. Y., Weeks, D. E., and Chen, W., Genome-wide analysis of disease progression in age-related macular degeneration., Hum Mol Genet, vol. 27, no. 5, pp. 929-940, 2018.
M. J. Martens and Logan, B. R., A group sequential test for treatment effect based on the Fine-Gray model., Biometrics, vol. 74, no. 3, pp. 1006-1013, 2018.
A. E. Fombah, Goldstein, S. T., Jarrett, O. D., Jalloh, M. I., El-Khorazaty, J., Lisk, D. Radcliffe, Legardy-Williams, J., Pratt, D. A., George, P. M., Russell, J. B. W., Schrag, S. J., Dawson, P., Deen, G. F., Carr, W., Lindblad, R., James, F., Bah, M. M., Yillia, J. F., Sandy, J. D., Turay, P. E., Conteh, M. - A., Slutsker, L., Mahon, B. E., Samai, M., and Seward, J. F., Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)., J Infect Dis, vol. 217, no. suppl_1, pp. S75-S80, 2018.
L. K. Weaver, Wilson, S. H., Lindblad, A. S., Churchill, S., Deru, K., Price, R. C., Williams, C. S., Orrison, W. W., Walker, J. M., Meehan, A., and Mirow, S., Hyperbaric oxygen for post-concussive symptoms in United States military service members: a randomized clinical trial., Undersea Hyperb Med, vol. 45, no. 2, pp. 129-156, 2018.
S. Chakraborty, Harro, C., DeNearing, B., Brubaker, J., Connor, S., Maier, N., Dally, L., Flores, J., A Bourgeois, L., Walker, R., and Sack, D. A., Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers., PLoS Negl Trop Dis, vol. 12, no. 4, p. e0006442, 2018.
M. Rao, Onkar, S., Peachman, K. K., White, Y., Trinh, H. V., Jobe, O., Zhou, Y., Dawson, P., Eller, M. A., Matyas, G. R., and Alving, C. R., Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans., J Infect Dis, vol. 218, no. 10, pp. 1541-1550, 2018.